Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe India | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Brazil | pt
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | nl
  • Belgium | fr
  • Bulgaria | bg
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • United Kingdom | en
  • Global | en
  • Novartis Foundation | en
  • Sandoz | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe India

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | nl
  • Belgium | fr
  • Brazil | pt
  • Bulgaria | bg
  • Canada | fr
  • Canada | en
  • Central America | es
  • Colombia | es
  • Czech Republic | en
  • Czech Republic | cs
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | fr
  • Switzerland | de
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About
      • Novartis in India
      • Global Drug Development
      • Strategy
      • Diversity and Inclusion
      • People and Culture
      • Arogya Parivar
      • India Site Locations
      • NIL Board of Directors
        • Mr. Christopher Snook
        • Mr. Sanjay Murdeshwar
        • Mr. Jai Hiremath
        • Ms. Sandra Martyres
        • Ms. Monaz Noble
        • Mr. Sanker Parameswaran
      • Contact
      About
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Diseases
      • Adverse Event Reporting
      Patients and Caregivers
    • Healthcare Professionals
      • Healthcare professional country resource
      • Novartis Pipeline
      • Adverse Event Reporting
      • Novartis Clinical Trials
      Healthcare Professionals
    • ESG
      • Ethical Behavior
        • Code of Ethics
        • SpeakUp
      • Ethics, Risk and Compliance
      • Access
      • Environmental Sustainability
      • Global Health
      ESG
    • Investors
      • Annual General Meeting
      • Corporate Policies
      • Financial Results
      • Stock Exchange Disclosures
      • Transfer of Shares to IEPF Demat Account
      • Novartis India Investors Contact
      • Novartis India Annual General Meeting
      • Novartis India Board of Directors
      Novartis India Investors
    • News
      • News Archive
      • Contacts
      News
    • Careers
      • Career Search
      • BioCamp
      • Meet the teams
      • Personal Growth
      • Early Talent
      • Well-being
      • Diversity and Inclusion
      • Awards and Recognition
      Careers
    • Coronavirus
      Coronavirus
    Home
  1. Home
  2. News
  3. News Archive
News Archive Navigation
  • All
  • Media Releases
icon

April 2020

  • Media ReleaseApr 28, 2020
    Novartis Group Financial Results – Q1 2020
    Novartis announced the company’s financial results for the first quarter of 2020

February 2020

  • Media ReleaseFeb 24, 2020
    Novartis launches Biome India, a digital innovation hub in Hyderabad; first in Asia
    Novartis launches Biome India, a digital innovation hub in Hyderabad; first in Asia Novartis launches Biome India, its first digital innovation hub in Asia Biome India will engage with startups and…

December 2019

  • Media ReleaseDec 20, 2019
    After 26 weeks gender neutral parental leave policy, Novartis India extends insurance benefit plans to LGBTI, single parents, live-in partners and their dependent children
    After 26 weeks gender neutral parental leave policy, Novartis India extends insurance benefit plans to LGBTI, single parents, live-in partners and their dependent children Extends medical cover to…

July 2019

  • Media ReleaseJul 17, 2019
    Novartis continues to build healthcare talent ecosystem; announces BioCamp 2019
    Novartis continues to build healthcare talent ecosystem; announces BioCamp 2019 BioCamp engages students around scientific advances to address unmet medical needs and entrepreneurial opportunities…
  • Media ReleaseJul 01, 2019
    Novartis announces 26 weeks gender neutral parental leave policy in India
    Novartis announces 26 weeks gender neutral parental leave policy in India New parental policy applicable to birthing and non-birthing parent Applies to cases of birth, adoption, surrogacy as per…

June 2019

  • Media ReleaseJun 15, 2019
    Novartis India Limited reconstitutes Board; appoints Sanjay Murdeshwar as Vice Chairman & Managing Director
    Novartis India Limited reconstitutes Board; appoints Sanjay Murdeshwar as Vice Chairman & Managing Director Mumbai, June 15, 2019 – At a meeting held in Mumbai today, the Board of Directors of…

July 2018

  • Media ReleaseJul 10, 2018
    Novartis in India invites applications for BioCamp 2018
    Novartis in India invites applications for BioCamp 2018 Opportunity for three bright students to avail customised internship BioCamp offers ~50 top tier students four-day hands-on experience with…

October 2017

  • Media ReleaseOct 03, 2017
    Novartis media release BioCamp India October 2017
    Novartis India invites applications for BioCamp 2017 Great opportunity for three bright students to avail internship BioCamp offers ~50 top tier students four-day hands-on experience with the…

May 2017

  • Media ReleaseMay 24, 2017
    Novartis India announces results for the quarter and year ended March 31, 2017
    Full year profits from continuing operations severly impacted by price controls Board recommends dividend of ₹10 per equity share of ₹ each At a meeting held in Mumbai today, the Board of Novartis…

April 2017

  • Media ReleaseApr 11, 2017
    Novartis Group appoints Milan Paleja as Country President, Novartis in India
    Novartis Group appoints Milan Paleja as Country President, Novartis in India Mumbai, April 11, 2018 Milan Paleja has been appointed Country President responsible for Novartis Group companies in…

November 2016

  • Media ReleaseNov 01, 2016
    Novartis India announces Q2 2016-17 Results
    Novartis India announces Q2 2016-17 Results

September 2016

  • Media ReleaseSep 02, 2016
    Sandoz HACk September 2016
    Sandoz HACk September 2016 Competition factsheet

Pagination

  • 1
  • 2
  • › Next page

Novartis India

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
  • Contacts
Media Center
  • News Archive
Our Portfolio
  • Novartis Clinical Pipeline
Other Novartis websites
  • Global site
  • Novartis MedHub India
Footer Bottom
© 2022 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Web Accessibility
  • Cookie Settings
  • Site Map
Novartis Site Directory
This site is intended for an audience in India